Teva, Allergan settle roles in opioid crisis for $4.25B, $2.37B respectively - Top Class Actions
Teva Can Reach $100 on Allergan Unit Acquisition | Barron's
Teva deal lets us double down on brands: Allergan CEO
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suits - The New York Times
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/LCGCPK3EYBF3PJZYOYFN26JDWQ.jpg "Teva buying Allergan, drops Mylan bid")
Teva buying Allergan, drops Mylan bid
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva buys Allergan's generic drug unit for $40.5B
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Teva Springs for $40.5B Allergan Generics Acquisition Instead of Mylan Bid - YouTube
Fla. secures $860M from CVS, Teva, Allergan and Endo to settle opioid case
Teva Can Benefit by Acquiring Allergan Generics
San Francisco reaches $58 million opioid settlement with Teva, Allergan | Business Insurance
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
What Exactly Did Allergan and Teva Sell to Impax? - TheStreet
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Teva's Multibillion-Dollar Purchase of Allergan Approved
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
Teva, Allergan Tweak Acquisition Agreement - WSJ
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Opioid Manufacturers Teva and Allergan Face Insurance Fraud Charges : Risk & Insurance
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
